APOE and Alzheimer disease: Cerebral blood flow reduction was found in both AD patients, human-expressing ApoE4 protein which predisposes to AD, and AD mice models, which contributes to the pathological progression of AD (Thambisetty et al., 2010; Michels et al., 2016; Korte, Nortley and Attwell 2020).